Heinrich Dreismann - 01 Jan 2026 Form 3 Insider Report for MAINZ BIOMED N.V. (MYNZ)

Role
Director
Signature
/s/ Heiner Dreismann
Issuer symbol
MYNZ
Transactions as of
01 Jan 2026
Net transactions value
$0
Form type
3
Filing time
26 Jan 2026, 16:05:53 UTC
Previous filing
06 Jun 2025
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dreismann Heinrich Director MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ, GERMANY /s/ Heiner Dreismann 26 Jan 2026 0001379372

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MYNZ Ordinary Shares 0 01 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MYNZ Employee Stock Option (Right to Buy) 01 Jan 2026 Ordinary Shares 17,500 $4.95 Direct F1
holding MYNZ Employee Stock Option (Right to Buy) 01 Jan 2026 Ordinary Shares 250 $302.80 Direct F2
holding MYNZ Employee Stock Option (Right to Buy) 01 Jan 2026 Ordinary Shares 1,950 $200.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the option vested upon grant on 03/04/2025; the remaining balance vests 25% on 03/24/26 and 25% on 03/04/2027.
F2 Fully vested.